Hospice DME spend is often treated as a census driven expense. As census rises or falls, leaders expect DME spend to move proportionally. In practice, DME behaves very differently. It functions more like a system shaped by utilization behavior, operational discipline, vendor responsiveness, and financial visibility.
Once a per diem contract is signed, most of the cost drivers that matter shift out of plain sight.
Additional charges do not usually appear as large, obvious line items. They surface quietly. Rental charges extend beyond expected timeframes. Pickup requests are delayed. User or licensing fees scale as teams grow. Called in or after hours order fees appear when workflows break down or urgency increases.
None of these costs are unusual on their own.
The problem is how they accumulate.
For example, consider a common scenario. A patient discharges late on a Friday. The clinical team completes documentation, but the equipment pickup request is delayed until Monday. The vendor does not retrieve the equipment until later in the week. Billing continues during that time, often unnoticed. The charge may be small on a single invoice, but across dozens or hundreds of discharges per year, the impact compounds.
Another example involves non formulary items. A specialty mattress or oxygen configuration is ordered to meet patient needs. It falls outside the bundled rate. The charge is approved quickly to avoid care delays. No one disputes the decision. The cost appears weeks later on an invoice, disconnected from the clinical moment that triggered it.
These are not failures of oversight.
They are symptoms of delayed visibility.
Finance teams do not miss these costs because they are inattentive. They miss them because the pricing model and operational workflows delay clarity. By the time trends are visible in aggregate, the opportunity to prevent them has already passed.
At that point, finance is forced into a reactive posture. Teams reconcile invoices line by line. Disputes are opened. Credits are requested. Staff time is consumed chasing accuracy rather than managing strategy.
Opaque pricing is not neutral. It is risky.
When finance leaders cannot clearly see what is included, what triggers additional charges, or how utilization translates into cost in near real time, forecasting becomes guesswork. Spend may technically comply with contract terms while still undermining predictability.
Predictable DME spend is not achieved by pushing the per diem lower.
It is achieved by building systems that surface cost drivers early enough to intervene.
Predictability is not the absence of cost. It is the absence of surprise.